ELPEN Pharmaceutical Investment Plan

ELPEN Pharmaceutical Inc intends to invest in Research, Development and Production of new Value-Added Medicines. The company plans to invest in the field of research and development by building a new Center for Applied Biomedical Research and a pharmaceutical plant with a strong export orientation.

The two new facilities concern the Attica Region. The investment has a total budget of 50.7 mn. euros and creates high domestic added value. It encourages employment by generating more than 150 new direct and indirect jobs of highly specialized scientists, while at the same time offering significant benefits for the development and support of the local and national economy.